CAS: 1346133-08-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY-2795050 REF: IN-DA009CCVCAS: 1346133-08-1 | 95% | To inquire | Thu 27 Mar 25 |
 | LY2795050 REF: TM-TQ0091CAS: 1346133-08-1 | 97.77% | To inquire | Thu 03 Apr 25 |
 | LY2795050 REF: 3D-WDC13308CAS: 1346133-08-1 | Min. 95% | 344.00 €~1,671.00 € | Thu 08 May 25 |
Ref: IN-DA009CCV
| 1mg | 106.00 € | ||
| 2mg | 157.00 € | ||
| 5mg | 179.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
LY2795050
CAS:1346133-08-1
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
Formula:
C23H22ClN3O2
Purity:
97.77%
Color and Shape:
Solid
Molecular weight:
407.89
Ref: TM-TQ0091
| 1mg | 52.00 € | ||
| 2mg | 74.00 € | ||
| 5mg | 116.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 298.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 127.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
LY2795050
CAS:1346133-08-1
LY2795050 is a drug that acts as a δ receptor agonist. It has been shown …
Formula:
C23H22ClN3O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
407.89 g/mol
Ref: 3D-WDC13308
| 1mg | 344.00 € | ||
| 5mg | 437.00 € | ||
| 10mg | 622.00 € | ||
| 25mg | 1,045.00 € | ||
| 50mg | 1,671.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
